A Northwestern Medicine report published last September explains how putting e-cigarettes in the same category as cigarettes could lead to misguided research and therefore erroneously inform policy.
Is the FDA failing to make such a differentiation?
Last September the FDA launched “The Real Cost” Youth E-Cigarette Prevention Campaign, a new effort aimed at deterring adolescents from taking up vaping. FDA Commissioner Dr. Scott Gottlieb called the rise in vaping an epidemic.
In response to this, several public health experts amongst whom Dr. Konstantinos Farsalinos said that the risk of dependence on nicotine and the risks associated with e-cigarette use cannot and shouldn’t be compared to the risks from smoking.
Farsalinos points out that the duty of public health officials is to weigh the benefits and adverse effects of any intervention and check where the balance lies. He adds that in the case of e-cigarettes, the benefits outweigh the adverse effects, and this needs to be taken into account.
There are many key differences between e-cigs and cigarettes
In line with Farsalinos’ arguments, the Northwestern report took a closer look at articles and studies that compare e-cigarettes to cigarettes, and points out that e-cigarettes should be investigated as a separate entity.
“There are enough key differences between cigarettes and these products, especially newer-generation devices, to show that they are not interchangeable nicotine delivery systems,” Olonoff said.
Read Further: Eurekalert